Cancer Vaccines at an Inflection Point

Session details:

Recent clinical successes have renewed enthusiasm for cancer vaccines and raised important questions about the future of the field. This presentation examines where cancer vaccines stand today, what recent advances signal for the broader oncology landscape, and what scientific and translational hurdles remain before these approaches can achieve widespread impact. Topics include:

• Have recent clinical results fundamentally changed the outlook for cancer vaccines?
• Which lessons are likely to translate across tumor types, disease settings, and vaccine platforms?
• What biological, translational, and clinical challenges still need to be addressed?
• Where are the greatest opportunities for future innovation and combination strategies?
• What will it take to expand the impact of cancer vaccines beyond today's early successes?